A lot of big data/Hadoop implementations are swimming against the currents of what recent history has taught about large scale computing, and the result is a significant amount of waste. So says Univa President and CEO Gary Tyreman, who claims that established HPC tools are more than capable of driving value where big data workloads are concerned. This is where Univa’s Grid Engine resource management software platform adds value for enterprises wading into the Hadoop pool. Univa is seeing new revenues (approx. 6% of their total in 2012) by enabling their customers to run Hadoop in a shared infrastructure model, which ultimately saves them significant dollars in infrastructure and support costs.
NineSigma has announced the launch of the Head Health Challenge on behalf of GE & the NFL. Partnering up to accelerate concussion research, diagnosis and treatment, the Head Health Initiative aims to develop new solutions to help diagnose mild traumatic brain injury. This initiative includes two components: a four-year $40 million research and development program to determine the key imaging biomarkers in the brain, and a two-year open innovation program to invest up to $20 million in research and technology to better understand and diagnose traumatic brain injury.
The NICO Myriad is now in the hands of TV stars operating on a baby with a hypothalamic hamartoma who had laughing seizures. Sound familiar? The script mirrors the story of Nico Bastolla, who NICO was named after, and will feature the Myriad in an episode of the new TNT medical drama series, Monday Mornings.
Attractiveness of medical plastics processing assets is extremely high and heading higher. As a result, there is significant payback in investment in new equipment for American medical molders and extruders. Venture capital firms that have invested heavily in America medical plastics processing assets in the last five years include: Kohlberg & Co. (Phillips Plastics), Baird Capital Partners and River Cities Capital Funds (MedPlast), and KRG Capital Partners (Vention).
Just what does it take to be a CEO of a successful med-tech startup? What does the journey look like for a CEO that has made it through the process of taking an idea and building a product and business around it? Those questions were answered during the CEO Roundtable at the Southeastern Medical Device Conference (SEMDA), which included the CEO of River Cities Capital Funds’ portfolio company EndoChoice.
New sales and marketing solution helps companies quickly and easily discover and use their best proposals, presentations and other collateral.
River Cities’ Rik Vandevenne and portfolio company KnowledgeTree’s CEO Daniel Chalef discuss tips for entrepreneurs seeking venture funding.
River Cities’ portfolio company Knowlagent, the leading provider of intraday management solutions, is rebranding itself as Intradiem.
To expand its line of endoscopy technology, River Cities’ portfolio company EndoChoice will merge with Peer Medical.
NineSigma featured on HiVelocityMedia.com regarding the importance of open innovation for middle market companies.